LifeMDs Weight Management Program offers virtual visits with licensed healthcare professionals who can prescribe FDA-approved GLP-1 medications like Wegovy and Zepbound when appropriate, plus access to nutrition support
Are GLP-1 Agonists Ever Used in Type 1 Diabetes
Keywords Information Type Research Article Information Copyright The Author(s), 2026
GLP-1 weight loss users significantly reduce their unit volume of food purchasing (-8.6%) and more revealingly of alcohol (-14.5%).[18] More recent, less accurate, survey research on GLP-1 weight-loss drug users from September 2023 suggests the following rank order of reported decreased consumption that features a big impact to the QSR and candy industries: Fast Food (77%) Pizza restaurants (74%) Confectionery (72%) Carbonated/sugary drinks (70%) Cookies/baked products (69%) Alcohol (66%)[19] Top foods where users report an increase in consumption: Fruits and vegetables 54% Weight-loss management foods (44%) Poultry and fish (38%)[20] GLP-1 drugs, unlike bariatric surgery, appear to have a strong effect on muting intrinsic desire for compulsive (and impulsive) eating and drinking

Reduced Food Cravings: Clinical studies using functional MRI scans have shown that patients on semaglutide or liraglutide exhibit lower activation in reward-related brain regions when exposed to high-calorie foods
Because excess weight is closely linked to insulin resistance, fatty liver disease, sleep apnoea, cardiovascular disease, and progression to type 2 diabetes, weight loss achieved with GLP-1 therapy can have wide-ranging metabolic benefits even before diabetes develops